ASOs designed and optimized to significantly enhance exon 3 skipping, increased a PD-L1-S isoform, and decrease the levels of PD-L1-L isoform, along with an unexpected pro-pyroptotic effect in tumor cells (see Fig. 5F) [223]. This evidence concerns the gene CD274 and neoplasm.